The recommendations and the way forward to fight human infections caused by influenza A (H1N1) in Brazil
- PMID: 38845845
- PMCID: PMC11154193
- DOI: 10.1016/j.nmni.2024.101434
The recommendations and the way forward to fight human infections caused by influenza A (H1N1) in Brazil
Abstract
Many recent outbreaks of influenza A (H1N1) in the world, especially in Brazil, it has become clear that the severity of the disease is not known in the same form. On Wednesday, June 7, 2023, Brazil notified the WHO of a fatal case of human infection with a variant of the influenza A(H1N1) virus of swine origin, this case was confirmed in a laboratory in the region of the interior state of Paraná. This is the first human infection caused by an influenza A (H1N1) virus reported in 2023 nationwide in Brazil. To mitigate H1N1 flu in Brazil, we urge the Brazillian government through its Ministry of Health to improve on mass awareness about the signs and symptoms of H1N1 flu among the Brazillians. The Brazillian government should also implement the One Health approach towards the control of H1N1 flu in Brazil, as we believe that these recommendations would go a long way in preventing future cases and the spread of H1N1 flu in Brazil. This article aims to present the clinical presentations of the H1N1 flu and the implications, recommendations and the way forward to protect the Brazilian population against the H1N1 flu.
Keywords: Animals; H1N1 subtype; Humans; Influenza A virus; Influenza human diagnosis.
© 2024 Published by Elsevier Ltd.
Conflict of interest statement
The authors declare that there no conflict of interest.
Similar articles
-
An insight into the swine-influenza A (H1N1) virus infection in humans.Lung India. 2011 Jan;28(1):34-8. doi: 10.4103/0970-2113.76299. Lung India. 2011. PMID: 21654984 Free PMC article.
-
[Recommendations of the Infectious Diseases Work Group (GTEI) of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) and the Infections in Critically Ill Patients Study Group (GEIPC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) for the diagnosis and treatment of influenza A/H1N1 in seriously ill adults admitted to the Intensive Care Unit].Med Intensiva. 2012 Mar;36(2):103-37. doi: 10.1016/j.medin.2011.11.020. Epub 2012 Jan 13. Med Intensiva. 2012. PMID: 22245450 Spanish.
-
The Spanish flu.Presse Med. 2022 Sep;51(3):104127. doi: 10.1016/j.lpm.2022.104127. Epub 2022 Jun 1. Presse Med. 2022. PMID: 35661699
-
Influenza a (H1N1) outbreak and challenges for pharmacotherapy.Indian J Physiol Pharmacol. 2009 Apr-Jun;53(2):113-26. Indian J Physiol Pharmacol. 2009. PMID: 20112815 Review.
-
Non-hydrolyzed in digestive tract and blood natural L-carnosine peptide ("bioactivated Jewish penicillin") as a panacea of tomorrow for various flu ailments: signaling activity attenuating nitric oxide (NO) production, cytostasis, and NO-dependent inhibition of influenza virus replication in macrophages in the human body infected with the virulent swine influenza A (H1N1) virus.J Basic Clin Physiol Pharmacol. 2013;24(1):1-26. doi: 10.1515/jbcpp-2012-0037. J Basic Clin Physiol Pharmacol. 2013. PMID: 23425625 Review.
References
-
- WHO. Influenza A (H1N1) variant virus in Brazil.https://www.who.int/emergencies/diseases-outbreak-news/item/2023-DON473.
-
- Akilimali A., Oduoye M.O., Biamba C., Cakwira H., Onesime J., Lopez K., et al. The main recommendations to fight human infections caused by avian influenza A (H5) and the way forward in Ecuador. IJS Global Health. 2023;6(2):e129. doi: 10.1097/GH9.0000000000000129. - DOI
Publication types
LinkOut - more resources
Full Text Sources